![Robert Plenge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Plenge
Teknisk/Vetenskaplig/F&U Direktör på
BRISTOL-MYERS SQUIBB COMPANY
Förmögenhet: 2 M $ per 2026-07-31
Profil
Robert M.
Plenge is currently Director at PhRMA Foundation and Chief Research Officer, EVP & Head-Research at Bristol Myers Squibb Co. Former positions include Independent Director at Translate Bio, Inc. from 2019 to 2021, VP-Translational Development & Research at Celgene Corp., Vice President & Head-Translational Medicine at Merck & Co., Inc. from 2013 to 2017, Associate Member-Broad Institute at The Brigham & Women's Hospital, Inc. from 2007 to 2013, and Associate Member at The Broad Institute, Inc. from 2007 to 2013.
Education includes a doctorate from Case Western Reserve University conferred in 2000 and an undergraduate degree from the University of California San Diego conferred in 1992.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-10 | 24 754 ( 0 % ) | 2 M $ | 2026-07-31 |
Aktiva positioner av Robert Plenge
| Företag | Position | Start |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Teknisk/Vetenskaplig/F&U Direktör | 2019-11-01 |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Robert Plenge
| Företag | Position | Slut |
|---|---|---|
| TRANSLATE BIO, INC. | Direktör/Styrelseledamot | 2021-09-14 |
| MERCK & CO., INC. | Företagsledare/Principal | 2017-05-01 |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Företagsledare/Principal | 2013-01-01 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Företagsledare/Principal | 2013-01-01 |
| CELGENE | Teknisk/Vetenskaplig/F&U Direktör | - |
Robert Plenges utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
83
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
